Healthcare provider profile · identity verified

David Budde, DO

Family Practice · BERLIN, WI · NPI 1245231034

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	435	118
Lisinopril	Lisinopril	302	78
Losartan Potassium	Losartan Potassium	295	85
Omeprazole	Omeprazole	282	75
Amlodipine Besylate	Amlodipine Besylate	275	81
Rosuvastatin Calcium	Rosuvastatin Calcium	262	68
Simvastatin	Simvastatin	249	60
Levothyroxine Sodium	Levothyroxine Sodium	248	57
Metoprolol Succinate	Metoprolol Succinate	199	55
Gabapentin	Gabapentin	195	39
Furosemide	Furosemide	184	43
Hydrochlorothiazide	Hydrochlorothiazide	172	52
Metformin Hcl	Metformin Hcl	171	43
Pantoprazole Sodium	Pantoprazole Sodium	159	40
Eliquis	Apixaban	142	31
Tamsulosin Hcl	Tamsulosin Hcl	142	36
Warfarin Sodium	Warfarin Sodium	141	27
Albuterol Sulfate Hfa	Albuterol Sulfate	133	50
Citalopram Hbr	Citalopram Hydrobromide	133	33
Metoprolol Tartrate	Metoprolol Tartrate	127	39
Metformin Hcl Er	Metformin Hcl	121	36
Allopurinol	Allopurinol	120	34
Finasteride	Finasteride	115	26
Escitalopram Oxalate	Escitalopram Oxalate	114	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	112	23
Clopidogrel	Clopidogrel Bisulfate	90	24
Trazodone Hcl	Trazodone Hcl	87	24
Glipizide Er	Glipizide	86	21
Duloxetine Hcl	Duloxetine Hcl	83	22
Pravastatin Sodium	Pravastatin Sodium	81	24
Atenolol	Atenolol	75	19
Tramadol Hcl	Tramadol Hcl	69	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	17
Triamcinolone Acetonide	Triamcinolone Acetonide	57	29
Ozempic	Semaglutide	56	13
Fluticasone Propionate	Fluticasone Propionate	54	22
Prednisone	Prednisone	54	24
Famotidine	Famotidine	53	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	15
Trulicity	Dulaglutide	51	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	49	14
Lorazepam	Lorazepam	44	suppressed
Lovastatin	Lovastatin	43	11
Oxybutynin Chloride Er	Oxybutynin Chloride	42	suppressed
Potassium Chloride	Potassium Chloride	42	14
Propranolol Hcl	Propranolol Hcl	42	suppressed
Nitroglycerin	Nitroglycerin	40	25
Doxazosin Mesylate	Doxazosin Mesylate	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Carvedilol	Carvedilol	37	suppressed
Fenofibrate	Fenofibrate	37	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	33	33
Ezetimibe	Ezetimibe	31	11
Sertraline Hcl	Sertraline Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Nystatin	Nystatin	23	11
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	19
Pregabalin	Pregabalin	21	suppressed
Topiramate	Topiramate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Piroxicam	Piroxicam	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	11
Cefdinir	Cefdinir	16	14
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Byetta	Exenatide	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Glipizide	Glipizide	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Digoxin	Digoxin	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Naproxen	Naproxen	11	suppressed
Terconazole	Terconazole	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error